Listar por autor "Cervantes, Andrés"
Mostrando ítems 1-5 de 5
-
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Isakoff, S. J.; Tabernero Caturla, Josep; Molife, L. R.; Soria, J.-C.; Vogelzang, N. J.; Argilés Martinez, Guillem; Cervantes, Andrés (Elsevier, 2020-05) -
Clinical management of metastatic colorectal cancer in the era of precision medicine
Ciardiello, Davide; Martini, Giulia; Napolitano, Stefania; Tabernero Caturla, Josep; Cervantes, Andrés; Ciardiello, Fortunato (Wiley, 2022-07) -
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Desai, Jayesh; Alonso-Casal, Guzman; Kim, Se Hyun; Cervantes, Andrés; Karasic, Thomas; MEDINA RODRIGUEZ, LAURA (Nature Portfolio, 2024-01) -
ESMO pays tribute to Professor José Baselga
Peters, S.; Tabernero Caturla, Josep; Giuliani, Rosa; Lordick, F.; Banerjee, Susana; Cervantes, Andrés (Elsevier, 2021-07) -
European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer
Martinelli, Erika; Arnold, Dirk; Stintzing, Sebastian; Van Cutsem, Eric; Tabernero Caturla, Josep; Cervantes, Andrés (Elsevier, 2023-04)